兄弟科技(002562) - 2021年3月3日投资者关系活动记录表

Group 1: Company Overview and Strategic Development - In the past three years, Brother Technology has accelerated its layout, expanding from leather chemicals and vitamins to include flavors and pharmaceuticals, with core projects in these new sectors officially launched in the second half of last year [1] - The company's first active pharmaceutical ingredient (API) product was Vitamin B1, with plans to introduce additional vitamin products [1] Group 2: Product Development and Production Capacity - The company aims to supply API-grade vitamin products through multifunctional workshops, with iodine contrast agents as a core product, and plans to produce specialty and patented APIs [3] - The first phase of the "20,000 tons of phenol and 31,100 tons of phenol derivatives" project was launched in October last year, with products gradually entering the market [3] - The "30,000 tons of natural flavor construction project" is scheduled to officially start construction in the first half of this year [3] Group 3: Market Position and Customer Base - The iodine contrast agent is chosen due to its large volume, rapid growth, and favorable supply structure, leveraging the company's well-established infrastructure in Jiujiang [3] - Current customers for iodine contrast agent intermediates include both domestic and international clients [3]